38995781|t|Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study.
38995781|a|Background: There are indications for sex-specific differences regarding the association between kallikrein-8 (KLK8) and cognitive impairment in early stages of Alzheimer's disease for which KLK8 may be an early blood-based biomarker. These may be due to different levels of sex hormones. To correctly interpret KLK8 blood concentrations, sex-specific analyses are needed. Objective: The aim of our exploratory study was to investigate sex-specific differences in blood-based KLK8 in participants of the population-based Heinz Nixdorf Recall study with different cognitive status and the association between KLK8 and sex hormones. Methods: In 290 participants (45% women, 69.7+-7.4 years (mean+-SD)) we investigated sex-specific serum KLK8 differences between cognitively unimpaired (CU, 43%) and cognitively impaired (CI) participants and the association between KLK8 and dehydroepiandrosteronsulfate (DHEAS), estradiol and testosterone, using adjusted multiple linear regression. Results: The mean+-SD KLK8 was similar for CU men (808.1+-729.6 pg/ml) and women (795.9+-577.7 pg/ml); adjusted mean-difference [95%-CI]: -95.3 [-324.1;133.5] pg/ml. KLK8 was lower in CI women (783.5+-498.7 pg/ml) than men (1048.4+-829 pg/ml); -261 [-493.1; -29] pg/ml. In men but not women, there was a weak indication for a positive slope between estradiol (11.9 [-0.4;24.3] pg/ml) and DHEAS (1.4 [-0.5;3.3] pg/ml) with KLK8, while testosterone had no impact. Conclusions: The results suggested a different role for KLK8 in the development of cognitive impairment in men and women, potentially influenced by sex hormones. To use blood KLK8 as an early biomarker, further research on hormonal regulation of KLK8 expression is needed as a part of the investigation of the KLK8 involvement in cognitive impairment and Alzheimer's disease pathology.
38995781	34	46	Kallikrein-8	Gene	11202
38995781	48	52	KLK8	Gene	11202
38995781	174	186	kallikrein-8	Gene	11202
38995781	188	192	KLK8	Gene	11202
38995781	198	218	cognitive impairment	Disease	MESH:D003072
38995781	238	257	Alzheimer's disease	Disease	MESH:D000544
38995781	268	272	KLK8	Gene	11202
38995781	389	393	KLK8	Gene	11202
38995781	553	557	KLK8	Gene	11202
38995781	685	689	KLK8	Gene	11202
38995781	742	747	women	Species	9606
38995781	812	816	KLK8	Gene	11202
38995781	837	848	cognitively	Disease	MESH:D003072
38995781	874	885	cognitively	Disease	MESH:D003072
38995781	941	945	KLK8	Gene	11202
38995781	950	978	dehydroepiandrosteronsulfate	Chemical	-
38995781	980	985	DHEAS	Chemical	-
38995781	988	997	estradiol	Chemical	MESH:D004958
38995781	1002	1014	testosterone	Chemical	MESH:D013739
38995781	1081	1085	KLK8	Gene	11202
38995781	1105	1108	men	Species	9606
38995781	1134	1139	women	Species	9606
38995781	1225	1229	KLK8	Gene	11202
38995781	1246	1251	women	Species	9606
38995781	1278	1281	men	Species	9606
38995781	1332	1335	men	Species	9606
38995781	1344	1349	women	Species	9606
38995781	1408	1417	estradiol	Chemical	MESH:D004958
38995781	1447	1452	DHEAS	Chemical	-
38995781	1481	1485	KLK8	Gene	11202
38995781	1493	1505	testosterone	Chemical	MESH:D013739
38995781	1577	1581	KLK8	Gene	11202
38995781	1604	1624	cognitive impairment	Disease	MESH:D003072
38995781	1628	1631	men	Species	9606
38995781	1636	1641	women	Species	9606
38995781	1696	1700	KLK8	Gene	11202
38995781	1767	1771	KLK8	Gene	11202
38995781	1831	1835	KLK8	Gene	11202
38995781	1851	1871	cognitive impairment	Disease	MESH:D003072
38995781	1876	1895	Alzheimer's disease	Disease	MESH:D000544
38995781	Association	MESH:D003072	11202
38995781	Association	MESH:D000544	11202

